Tara Bancroft
Stock Analyst at TD Cowen
(2.91)
# 1,457
Out of 5,124 analysts
9
Total ratings
75%
Success rate
26.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Maintains: Buy | $14 → $20 | $11.25 | +77.78% | 4 | Oct 30, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $95 → $80 | $69.68 | +14.81% | 1 | Sep 15, 2025 | |
| TGTX TG Therapeutics | Initiates: Buy | $50 | $29.41 | +70.01% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $82.27 | -20.99% | 1 | Sep 24, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.32 | +657.58% | 1 | Apr 29, 2024 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $6.57 | - | 1 | Aug 31, 2022 |
Ocular Therapeutix
Oct 30, 2025
Maintains: Buy
Price Target: $14 → $20
Current: $11.25
Upside: +77.78%
Lantheus Holdings
Sep 15, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $69.68
Upside: +14.81%
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $29.41
Upside: +70.01%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $82.27
Upside: -20.99%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.32
Upside: +657.58%
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $6.57
Upside: -